INTERNATIONAL PATENT: MODERNATX, INC., MERCK SHARP & DOHME LLC FILES APPLICATION FOR "INDIVIDUALIZED NEOANTIGEN VACCINES FOR THE TREATMENT OF BLADDER CANCER"

GENEVA, April 29 -- MODERNATX, INC. (325 Binney StreetCambridge, Massachusetts 02142), MERCK SHARP & DOHME LLC (126 East Lincoln AvenueRahway, New Jersey 07065) filed a patent application (PCT/US2025/051103) for "INDIVIDUALIZED NEOANTIGEN VACCINES FOR THE TREATMENT OF BLADDER CANCER" on Oct 15, 2025. With publication no. WO/2026/085242, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BROWN, Michelle (c/o ModernaTX, Inc., 325 Binney StreetCambridge, Massachusetts 02141), ZHU, Lili (c/o ModernaTX, Inc., 325 Binney StreetCam...